+149.5%
NTAP vs THC
+423.7%
-274.2%
-42.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.5% | -0.3% | -2.2% | -2.5% |
| 7D | +7.2% | +1.0% | +6.2% | +7.1% |
| 30D | -18.4% | +5.3% | -23.7% | -19.0% |
| 3M | -11.3% | +7.1% | -18.4% | -12.3% |
| 6M | +53.8% | +46.0% | +7.7% | +44.3% |
| YTD | +72.0% | +43.9% | +28.0% | +60.2% |
| 1Y | +68.0% | +45.4% | +22.6% | +55.8% |
| 3Y | +149.5% | +421.3% | -271.8% | +69.0% |
| All | +149.5% | +423.7% | -274.2% | +69.0% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling